Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.61 | N/A |
| PEG Ratio (TTM) | 6.61 | N/A |
| P/S Ratio (TTM) | 6.09 | N/A |
| P/B Ratio (TTM) | 9.95 | N/A |
| P/FCF Ratio (TTM) | 66.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.25 | N/A |
| Price to 5YR AVG FCF Ratio | 4.05 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 19.28% | N/A |
| ROE (TTM) | 29.29% | N/A |
| Net Profit Margin (TTM) | 19.28% | N/A |
| ROIC 5YR AVG | 37.74% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.31% | 19.02% | 21.46% |
| Revenue | 1.58% | 17.52% | 20.04% |
| Net Income | 5.25% | 29.94% | 29.23% |
| Cash Flow | 149.28% | 31.40% | 19.98% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.18 | N/A |
| Quick Ratio (TTM) | 1.17 | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | 44.83 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.99 | N/A |
| LTL to 5YR AVG FCF | 0.49 | N/A |
| Shares Outstanding Growth 5YR AVG | 9.29% | N/A |